-
1
-
-
33646238684
-
Epidemiology of Hepatitis C virus infection
-
Sy T, Jamal M (2006) Epidemiology of Hepatitis C virus infection. Int J Med Sci 3: 41-46.
-
(2006)
Int J Med Sci
, vol.3
, pp. 41-46
-
-
Sy, T.1
Jamal, M.2
-
2
-
-
0035934568
-
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial
-
Manns MP, McHutchison JG, Gordon SC, Rustgi VK, Shiffrman M, et al. (2001) Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 358: 958-965.
-
(2001)
Lancet
, vol.358
, pp. 958-965
-
-
Manns, M.P.1
McHutchison, J.G.2
Gordon, S.C.3
Rustgi, V.K.4
Shiffrman, M.5
-
3
-
-
33747797031
-
Treating viral hepatitis C: Efficacy, side effects, and complications
-
Manns M, Wedemeyer H, Cornberg M (2006) Treating viral hepatitis C: efficacy, side effects, and complications. Gut 55: 1350-1359.
-
(2006)
Gut
, vol.55
, pp. 1350-1359
-
-
Manns, M.1
Wedemeyer, H.2
Cornberg, M.3
-
5
-
-
0036828784
-
The burden of hepatitis C in the United States
-
Kim WR (2002) The burden of hepatitis C in the United States. Hepatology 36 (Suppl): S30-S34.
-
(2002)
Hepatology
, vol.36
, Issue.SUPPL.
-
-
Kim, W.R.1
-
6
-
-
0034767753
-
Antiviral actions of interferons
-
Samuel CE (2001) Antiviral actions of interferons. Clin Microbiol Rev 14: 778-809.
-
(2001)
Clin Microbiol Rev
, vol.14
, pp. 778-809
-
-
Samuel, C.E.1
-
7
-
-
0034467738
-
The human interferon alpha species and receptors
-
Pestka S (2000) The human interferon alpha species and receptors. Biopolymers 55: 254-287.
-
(2000)
Biopolymers
, vol.55
, pp. 254-287
-
-
Pestka, S.1
-
8
-
-
0033764515
-
Interferon-induced gene expression and signaling in human hepatoma cell lines
-
Melen K, Keskinen P, Lehtonen A, Julkunen I (2000) Interferon-induced gene expression and signaling in human hepatoma cell lines. J Hepatol 33: 764-772.
-
(2000)
J Hepatol
, vol.33
, pp. 764-772
-
-
Melen, K.1
Keskinen, P.2
Lehtonen, A.3
Julkunen, I.4
-
9
-
-
0036211034
-
Interferon alpha activates multiple STAT signals and down regulates C-Met in primary human hepatocytes
-
Radaeva S, Jaruga B, Hong F, Kim WH, Fan S, et al. (2002) Interferon alpha activates multiple STAT signals and down regulates C-Met in primary human hepatocytes. Gastroenterology 122: 1020-1034.
-
(2002)
Gastroenterology
, vol.122
, pp. 1020-1034
-
-
Radaeva, S.1
Jaruga, B.2
Hong, F.3
Kim, W.H.4
Fan, S.5
-
10
-
-
1842480410
-
Host factors and failure of interferon-alpha treatment in hepatitis C virus
-
Gao B, Hong F, Radaeva S (2004) Host factors and failure of interferon-alpha treatment in hepatitis C virus. Hepatology 39: 880-890.
-
(2004)
Hepatology
, vol.39
, pp. 880-890
-
-
Gao, B.1
Hong, F.2
Radaeva, S.3
-
11
-
-
0030936627
-
GAS elements: A few nucleotides with a major impact on cytokine-induced gene expression
-
Decker T, Kovarik P, Meinke A (1997) GAS elements: a few nucleotides with a major impact on cytokine-induced gene expression. J Interferon Cytokine Res 17: 121-134.
-
(1997)
J Interferon Cytokine Res
, vol.17
, pp. 121-134
-
-
Decker, T.1
Kovarik, P.2
Meinke, A.3
-
12
-
-
0031657551
-
How cells respond to interferons
-
Stark GR, Kerr IM, William BR, Silverman RH, Schreiber RD (1998) How cells respond to interferons. Annu Rev Biochem 67: 227-264.
-
(1998)
Annu Rev Biochem
, vol.67
, pp. 227-264
-
-
Stark, G.R.1
Kerr, I.M.2
William, B.R.3
Silverman, R.H.4
Schreiber, R.D.5
-
13
-
-
7244255836
-
Getting the message across, STAT! Design principles of a molecular signaling circuit
-
Vinkemeier U (2004) Getting the message across, STAT! Design principles of a molecular signaling circuit. J Cell Biol 167: 197-201.
-
(2004)
J Cell Biol
, vol.167
, pp. 197-201
-
-
Vinkemeier, U.1
-
14
-
-
20844441802
-
Interferons alpha, beta, gamma each inhibit hepatitis C virus replication at the level of internal ribosome entry site-mediated translation
-
Dash S, Prabhu R, Hazari S, Bastian F, Garry R, et al. (2005) Interferons alpha, beta, gamma each inhibit hepatitis C virus replication at the level of internal ribosome entry site-mediated translation. Liver Int 25: 580-594.
-
(2005)
Liver Int
, vol.25
, pp. 580-594
-
-
Dash, S.1
Prabhu, R.2
Hazari, S.3
Bastian, F.4
Garry, R.5
-
15
-
-
0034888396
-
Effect of alpha interferon on the hepatitis C virus replicon
-
Guo J, Bichko VV, Seeger C (2001) Effect of alpha interferon on the hepatitis C virus replicon. J Virol 75: 8516-8523.
-
(2001)
J Virol
, vol.75
, pp. 8516-8523
-
-
Guo, J.1
Bichko, V.V.2
Seeger, C.3
-
16
-
-
0036838695
-
Comparative analysis of anti-hepatitis C virus activity and gene expression mediated by alpha, beta, and gamma interferons
-
Cheney IW, Lai VCH, Zhong W, Brodhag T, Dempsey S, et al. (2002) Comparative analysis of anti-hepatitis C virus activity and gene expression mediated by alpha, beta, and gamma interferons. J Virol 76: 11148-11154.
-
(2002)
J Virol
, vol.76
, pp. 11148-11154
-
-
Cheney, I.W.1
Lai, V.C.H.2
Zhong, W.3
Brodhag, T.4
Dempsey, S.5
-
17
-
-
0036191172
-
Interferon-g inhibits replication of subgenomic and genomic hepatitis C virus RNAs
-
Frese M, Schwarzle V, Barth K, Krieger, Lohmann V, et al. (2002) Interferon-g inhibits replication of subgenomic and genomic hepatitis C virus RNAs. Hepatology 35: 694-703.
-
(2002)
Hepatology
, vol.35
, pp. 694-703
-
-
Frese, M.1
Schwarzle, V.2
Barth, K.3
Krieger, L.V.4
-
18
-
-
0033940177
-
Genotype and viral load as prognostic indicators in the treatment of hepatitis C
-
Trepo C (2000) Genotype and viral load as prognostic indicators in the treatment of hepatitis C. J Viral Hepat 7: 250-257.
-
(2000)
J Viral Hepat
, vol.7
, pp. 250-257
-
-
Trepo, C.1
-
19
-
-
0033636884
-
Hepatitis C virus and interferon resistance
-
Taylor DR, Shi ST, Lai MM (2000) Hepatitis C virus and interferon resistance. Microbes Infect 2: 1743-1756.
-
(2000)
Microbes Infect
, vol.2
, pp. 1743-1756
-
-
Taylor, D.R.1
Shi, S.T.2
Lai, M.M.3
-
20
-
-
0036211313
-
To interfere and to anti-interfere: The interplay between hepatitis C virus and interferon
-
He Y, Katze MG (2002) To interfere and to anti-interfere: the interplay between hepatitis C virus and interferon. Viral Immunol 15: 95-119.
-
(2002)
Viral Immunol
, vol.15
, pp. 95-119
-
-
He, Y.1
Katze, M.G.2
-
21
-
-
36049014040
-
Reduced expression of Jak-1 and Tyk-2 proteins leads to interferon resistance in hepatitis C virus replicon
-
Hazari S, Taylor L, Haque S, Garry RF, Florman S, et al. (2007) Reduced expression of Jak-1 and Tyk-2 proteins leads to interferon resistance in hepatitis C virus replicon. Virol J 4: 89.
-
(2007)
Virol J
, vol.4
, pp. 89
-
-
Hazari, S.1
Taylor, L.2
Haque, S.3
Garry, R.F.4
Florman, S.5
-
22
-
-
77749314519
-
Impaired antiviral activity of interferon alpha in Huh-7 cells with defective Jak-Stat pathway
-
Hazari S, Chandra PK, Poat B, Datta S, Garry RF, et al. (2010) Impaired antiviral activity of interferon alpha in Huh-7 cells with defective Jak-Stat pathway. Virol J 7: 36.
-
(2010)
Virol J
, vol.7
, pp. 36
-
-
Hazari, S.1
Chandra, P.K.2
Poat, B.3
Datta, S.4
Garry, R.F.5
-
23
-
-
26644465312
-
Modification of the STAT1 SH2 domain broadly improves interferon efficacy in proportion to p300/CREB-binding protein coactivator recruitment
-
Zhang Y, Takami K, Lo MS, Huang G, Yu Q, et al. (2005) Modification of the STAT1 SH2 domain broadly improves interferon efficacy in proportion to p300/CREB-binding protein coactivator recruitment. J Biol Chem 280: 34306-34315.
-
(2005)
J Biol Chem
, vol.280
, pp. 34306-34315
-
-
Zhang, Y.1
Takami, K.2
Lo, M.S.3
Huang, G.4
Yu, Q.5
-
24
-
-
33646355721
-
Tyrosine phosphorylation is required for funtioncal activation of disulphide-containing constitutive active Stat mutants
-
Liddle FJ, Alvarez JV, Poli V, Frank DA (2006) Tyrosine phosphorylation is required for funtioncal activation of disulphide-containing constitutive active Stat mutants. Biochemistry 45: 5599-5605.
-
(2006)
Biochemistry
, vol.45
, pp. 5599-5605
-
-
Liddle, F.J.1
Alvarez, J.V.2
Poli, V.3
Frank, D.A.4
-
25
-
-
20444375441
-
Pilot study of interferon gamma for hepatitis C
-
Soza A, Heller T, Ghany M, Lutchman G, Liang TJ, et al. (2005) Pilot study of interferon gamma for hepatitis C. J Hepatol 43: 67-71.
-
(2005)
J Hepatol
, vol.43
, pp. 67-71
-
-
Soza, A.1
Heller, T.2
Ghany, M.3
Lutchman, G.4
Liang, T.J.5
-
26
-
-
0025963882
-
High doses of recombinant alpha interferon or gamma interferon for chronic hepatitis C: A randomized, controlled trial
-
Saez-Royuela F, Porres JC, Moreno A, Castillo I, Martinez G, et al. (1991) High doses of recombinant alpha interferon or gamma interferon for chronic hepatitis C: a randomized, controlled trial. Hepatology 13: 327-331.
-
(1991)
Hepatology
, vol.13
, pp. 327-331
-
-
Saez-Royuela, F.1
Porres, J.C.2
Moreno, A.3
Castillo, I.4
Martinez, G.5
-
27
-
-
0036119059
-
Interferon-gamma brings additive antiviral environment when combined with interferon alpha in atients with chronic hepatitis C
-
Kumashiro R, Ide T, Sasaki M, Murashima S, Suzuki H, et al. (2002) Interferon-gamma brings additive antiviral environment when combined with interferon alpha in atients with chronic hepatitis C. Hepatol Res 22: 20-26.
-
(2002)
Hepatol Res
, vol.22
, pp. 20-26
-
-
Kumashiro, R.1
Ide, T.2
Sasaki, M.3
Murashima, S.4
Suzuki, H.5
-
28
-
-
0033529704
-
STAT3 as an oncogene
-
Bromberg JF, Wrzeszcznska MH, Devgan G, Zhao YH, Pestell RG, et al. (1999) STAT3 as an oncogene. Cells 98: 295-303.
-
(1999)
Cells
, vol.98
, pp. 295-303
-
-
Bromberg, J.F.1
Wrzeszcznska, M.H.2
Devgan, G.3
Zhao, Y.H.4
Pestell, R.G.5
-
29
-
-
0030936627
-
GAS elements: A few nucleotides with a major impact on cytokine-induced gene expression
-
Decker T, Kovarik P, Meinke A (1997) GAS elements: a few nucleotides with a major impact on cytokine-induced gene expression. J Interferon cytokine Res 17: 121-134.
-
(1997)
J Interferon Cytokine Res
, vol.17
, pp. 121-134
-
-
Decker, T.1
Kovarik, P.2
Meinke, A.3
-
30
-
-
71049192398
-
Molecular mechanisms of IFN-gamma to up-regulate MHC class I antigen processing and presentation
-
Zhou F (2009) Molecular mechanisms of IFN-gamma to up-regulate MHC class I antigen processing and presentation. Int Rev Immunol 28: 239-260.
-
(2009)
Int Rev Immunol
, vol.28
, pp. 239-260
-
-
Zhou, F.1
-
31
-
-
20144367694
-
Implications of an antiparallel dimeric structure of nonphosphorylated STAT1 for the activation-inactivation cycle
-
Zhong M, Henriksen MA, Takeuchi K, Schaefer O, Liu B, et al. (2005) Implications of an antiparallel dimeric structure of nonphosphorylated STAT1 for the activation-inactivation cycle. Proc Natl Acad Sci U S A 102: 3966-3971.
-
(2005)
Proc Natl Acad Sci U S A
, vol.102
, pp. 3966-3971
-
-
Zhong, M.1
Henriksen, M.A.2
Takeuchi, K.3
Schaefer, O.4
Liu, B.5
-
32
-
-
77954921919
-
Induction and evasion of innate antiviral response by hepatitis C virus
-
Lemon SM (2010) Induction and evasion of innate antiviral response by hepatitis C virus. J Biol Chem 285: 22741-22747.
-
(2010)
J Biol Chem
, vol.285
, pp. 22741-22747
-
-
Lemon, S.M.1
-
33
-
-
33845783282
-
Intrahepatic mRNA levels of type I interferon receptor and interferon stimulated genes in genotype 1b chronic hepatitis C
-
Taniguchi H, Iwasaki Y, Takahashi A, Shimomura H, Moriya A, et al. (2007) Intrahepatic mRNA levels of type I interferon receptor and interferon stimulated genes in genotype 1b chronic hepatitis C. Intervirology 50: 32-39.
-
(2007)
Intervirology
, vol.50
, pp. 32-39
-
-
Taniguchi, H.1
Iwasaki, Y.2
Takahashi, A.3
Shimomura, H.4
Moriya, A.5
-
34
-
-
0031944679
-
Expression of interferon receptor genes (IFNAR1 and IFNAR2 mRNA) in the liver may predict outcome after interferon therapy in patients with chronic genotype 2a or 2b hepatitis C virus infection
-
Morita K, Tanaka K, Saito S, Kitamura T, Kondo M, et al. (1998) Expression of interferon receptor genes (IFNAR1 and IFNAR2 mRNA) in the liver may predict outcome after interferon therapy in patients with chronic genotype 2a or 2b hepatitis C virus infection. J Clin Gastroenterol 26: 135-140.
-
(1998)
J Clin Gastroenterol
, vol.26
, pp. 135-140
-
-
Morita, K.1
Tanaka, K.2
Saito, S.3
Kitamura, T.4
Kondo, M.5
-
35
-
-
12144287341
-
Type 1 interferon receptor and response to interferon therapy in chronic hepatitis C patients: A prospective study
-
Fujiwara D, Hino K, Yamaguchi Y, Kubo Y, Yamashita S, et al. (2004) Type 1 interferon receptor and response to interferon therapy in chronic hepatitis C patients: a prospective study. J Viral hepat 11: 136-140.
-
(2004)
J Viral Hepat
, vol.11
, pp. 136-140
-
-
Fujiwara, D.1
Hino, K.2
Yamaguchi, Y.3
Kubo, Y.4
Yamashita, S.5
-
36
-
-
22644444813
-
Expression of interferon-alpha/beta receptor protein in liver of patients with hepatitis C virus- related chronic liver disease
-
Meng XW, Chi BR, Chen LG, Zhang LL, Zhuang Y, et al. (2005) Expression of interferon-alpha/beta receptor protein in liver of patients with hepatitis C virus- related chronic liver disease. World J Gastroenterol 11: 3962-3965.
-
(2005)
World J Gastroenterol
, vol.11
, pp. 3962-3965
-
-
Meng, X.W.1
Chi, B.R.2
Chen, L.G.3
Zhang, L.L.4
Zhuang, Y.5
-
37
-
-
68949117721
-
Variants in Interferon-alpha pathway genes and response to pegylated interferon-alpha 2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C Antiviral Long-term treatment against Cirrhosis trial
-
Welzel TM, Morgan TR, Bonkovsky HL, Naishadham D, Pfeiffer RM, et al. (2009) Variants in Interferon-alpha pathway genes and response to pegylated interferon-alpha 2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C Antiviral Long-term treatment against Cirrhosis trial. Hepatology 49: 1847-1858.
-
(2009)
Hepatology
, vol.49
, pp. 1847-1858
-
-
Welzel, T.M.1
Morgan, T.R.2
Bonkovsky, H.L.3
Naishadham, D.4
Pfeiffer, R.M.5
-
38
-
-
58249084172
-
Virus induced unfolded protein response attenuates antiviral defenses via phosphorylationdependent degradation of the type I interferon receptor
-
Liu J, HuangFu WC, Kumar SKG, Qian J, Caset JP, et al. (2009) Virus induced unfolded protein response attenuates antiviral defenses via phosphorylationdependent degradation of the type I interferon receptor. Cell Host Microbe 5: 72-83.
-
(2009)
Cell Host Microbe
, vol.5
, pp. 72-83
-
-
Liu, J.1
Huangfu, W.C.2
Kumar, S.K.G.3
Qian, J.4
Caset, J.P.5
-
39
-
-
19044361835
-
Hepatic gene expression discriminates responders from non-responders in treatment of chronic hepatitis C viral infection
-
Chen L, Borozan I, Feld J, Sun J, Tannis LL, et al. (2005) Hepatic gene expression discriminates responders from non-responders in treatment of chronic hepatitis C viral infection. Gastroneterology 128: 1437-1444.
-
(2005)
Gastroneterology
, vol.128
, pp. 1437-1444
-
-
Chen, L.1
Borozan, I.2
Feld, J.3
Sun, J.4
Tannis, L.L.5
-
40
-
-
77249169773
-
Cell-type specific gene expression signature in liver underlines response to interferon therapy in chronic hepatitis C virus infection
-
Chen L, Borozan I, Sun J, Guindi M, Fischer S, et al. (2010) Cell-type specific gene expression signature in liver underlines response to interferon therapy in chronic hepatitis C virus infection. Gastroenterology 138: 1123-1133.
-
(2010)
Gastroenterology
, vol.138
, pp. 1123-1133
-
-
Chen, L.1
Borozan, I.2
Sun, J.3
Guindi, M.4
Fischer, S.5
-
41
-
-
44349109098
-
Interferon signaling and treatment outcome in chronic hepatitis C
-
Sarasin-Filipowicz M, Oakeley EJ, Duong FHT, Christen V, Terracciano L, et al. (2008) Interferon signaling and treatment outcome in chronic hepatitis C. Proc Natl Acad Sci U S A 105: 7034-7039.
-
(2008)
Proc Natl Acad Sci U S A
, vol.105
, pp. 7034-7039
-
-
Sarasin-Filipowicz, M.1
Oakeley, E.J.2
Duong, F.H.T.3
Christen, V.4
Terracciano, L.5
-
42
-
-
34249279852
-
Systemic and specific delivery of small interfering RNA to the liver mediated by apolipoprotein A-1
-
Kim SI, Shin D, Choi TH, Lee JC, Cheon GJ, et al. (2007) Systemic and specific delivery of small interfering RNA to the liver mediated by apolipoprotein A-1. Mol Ther 15: 1145-1152.
-
(2007)
Mol Ther
, vol.15
, pp. 1145-1152
-
-
Kim, S.I.1
Shin, D.2
Choi, T.H.3
Lee, J.C.4
Cheon, G.J.5
-
43
-
-
67349183756
-
Development of lipoid-siRNA formulations for systemic delivery to the liver
-
Akinc A, Goldberg M, Qin J, Dorkin JR, Gamba-Vitalo C, et al. (2009) Development of lipoid-siRNA formulations for systemic delivery to the liver. Mol Ther 17: 872-879.
-
(2009)
Mol Ther
, vol.17
, pp. 872-879
-
-
Akinc, A.1
Goldberg, M.2
Qin, J.3
Dorkin, J.R.4
Gamba-Vitalo, C.5
|